Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Customized Chemotherapy vs Standard of Care in Advanced NSCLC
NCT00499109Phase 3Completed
- Sponsor
- Moffitt Cancer Center
- Start
- May 2007
- Primary completion
- Apr 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 3
01
Overview
A Phase 3 trial of docetaxel, vinorelbine, carboplatin, gemcitabine in non-small cell lung cancer (NSCLC), sponsored by Moffitt Cancer Center. Started May 2007; status: completed.
02
Drugs
docetaxelvinorelbinecarboplatingemcitabine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00499109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499109.